Core Viewpoint - Jiangyin Huaxin Precision Technology Co., Ltd. (Huaxin Precision) was listed on the Shanghai Stock Exchange, with a closing price of 69.30 yuan, reflecting a significant increase of 272.58% from the opening price of 65.00 yuan, and a total market capitalization of 12.124 billion yuan [1]. Company Overview - Huaxin Precision specializes in the research, development, production, and sales of precision stamping products, primarily focusing on various types of precision stamping iron cores and related precision stamping molds [1]. - The controlling shareholder before the public offering was Jiangyin Susong Investment Co., Ltd., holding 55.78% of the shares directly and an additional 4.59% indirectly through subsidiaries, totaling 60.37% [1][2]. Financial Performance - In the years 2022 to 2024, Huaxin Precision reported revenues of 1.191 billion yuan, 1.189 billion yuan, and 1.420 billion yuan, respectively, with net profits of 113.73 million yuan, 155.82 million yuan, and 149.65 million yuan [7]. - The company’s total assets increased from 1.329 billion yuan in 2022 to 1.837 billion yuan in 2024, while the equity attributable to shareholders rose from 724.52 million yuan to 1.040 billion yuan during the same period [8]. IPO Details - The company issued 43.7375 million new shares, accounting for 25% of the total share capital post-issue, at an issue price of 18.60 yuan per share, raising a total of 813.5175 million yuan [4][6]. - The net proceeds from the offering amounted to 727.1896 million yuan after deducting issuance costs of 86.3279 million yuan [6][4]. Future Projections - For the first half of 2025, Huaxin Precision achieved a revenue of 751.6131 million yuan, representing a year-on-year growth of 19.40%, with a net profit of 98.345 million yuan, up 13.52% [10]. - The company anticipates revenue for the first nine months of 2025 to be between 122.0487 million yuan and 124.01591 million yuan, with expected net profits ranging from 131.7472 million yuan to 161.0243 million yuan, indicating a year-on-year growth of 16.03% to 41.81% [10].
华新精科上市募8亿首日涨273% 去年净利降现金流屡负